| Transdermal protein delivery by a coadministered peptide identified via phage display Y Chen, Y Shen, X Guo, C Zhang, W Yang, M Ma, S Liu, M Zhang, ... Nature biotechnology 24 (4), 455-460, 2006 | 286 | 2006 |
| YAP promotes erlotinib resistance in human non-small cell lung cancer cells PC Hsu, B You, YL Yang, WQ Zhang, YC Wang, Z Xu, Y Dai, S Liu, ... Oncotarget 7 (32), 51922, 2016 | 124 | 2016 |
| Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells B You, YL Yang, Z Xu, Y Dai, S Liu, JH Mao, O Tetsu, H Li, DM Jablons, ... Oncotarget 6 (6), 4357, 2015 | 116 | 2015 |
| Targeting YAP in malignant pleural mesothelioma WQ Zhang, YY Dai, PC Hsu, H Wang, L Cheng, YL Yang, YC Wang, ... Journal of cellular and molecular medicine 21 (11), 2663-2676, 2017 | 62 | 2017 |
| Coumestrol from the national cancer Institute’s natural product library is a novel inhibitor of protein kinase CK2 S Liu, D Hsieh, YL Yang, Z Xu, C Peto, DM Jablons, L You BMC Pharmacology and Toxicology 14, 1-9, 2013 | 55 | 2013 |
| YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cells Y Dai, S Liu, WQ Zhang, YL Yang, P Hang, H Wang, L Cheng, PC Hsu, ... Oncotarget 8 (3), 4096, 2017 | 53 | 2017 |
| Structural and functional analysis of cyclin D1 reveals p27 and substrate inhibitor binding requirements S Liu, JK Bolger, LO Kirkland, PN Premnath, C McInnes ACS chemical biology 5 (12), 1169-1182, 2010 | 34 | 2010 |
| Cucurbitacin E inhibits the Yes‑associated protein signaling pathway and suppresses brain metastasis of human non‑small cell lung cancer in a murine model PC Hsu, B Tian, YL Yang, YC Wang, S Liu, A Urisman, CT Yang, Z Xu, ... Oncology reports 42 (2), 697-707, 2019 | 31 | 2019 |
| Inhibition of yes‐associated protein suppresses brain metastasis of human lung adenocarcinoma in a murine model PC Hsu, J Miao, Z Huang, YL Yang, Z Xu, J You, Y Dai, CC Yeh, G Chan, ... Journal of cellular and molecular medicine 22 (6), 3073-3085, 2018 | 31 | 2018 |
| The crystal structure of the protein kinase HIPK2 reveals a unique architecture of its CMGC-insert region C Agnew, L Liu, S Liu, W Xu, L You, W Yeung, N Kannan, D Jablons, ... Journal of Biological Chemistry 294 (37), 13545-13559, 2019 | 28 | 2019 |
| Optimization of non-ATP competitive CDK/cyclin groove inhibitors through REPLACE-mediated fragment assembly S Liu, PN Premnath, JK Bolger, TL Perkins, LO Kirkland, G Kontopidis, ... Journal of medicinal chemistry 56 (4), 1573-1582, 2013 | 23 | 2013 |
| Iterative conversion of cyclin binding groove peptides into druglike CDK inhibitors with antitumor activity PN Premnath, SN Craig, S Liu, EL Anderson, AI Grigoroudis, G Kontopidis, ... Journal of Medicinal Chemistry 58 (1), 433-442, 2015 | 14 | 2015 |
| Fragment based discovery of arginine isosteres through REPLACE: Towards non-ATP competitive CDK inhibitors PN Premnath, S Liu, T Perkins, J Abbott, E Anderson, C McInnes Bioorganic & medicinal chemistry 22 (1), 616-622, 2014 | 12 | 2014 |
| Cyclin based inhibitors of CDK2 and CDK4 C McInnes, S Liu US Patent 8,566,072, 2013 | 11 | 2013 |
| Inhibition of cyclin‐dependent kinase 7 down‐regulates yes‐associated protein expression in mesothelioma cells J Miao, H Kyoyama, L Liu, G Chan, Y Wang, A Urisman, YL Yang, S Liu, ... Journal of cellular and molecular medicine 24 (1), 1087-1098, 2020 | 7 | 2020 |
| Benzamide capped peptidomimetics as non-ATP competitive inhibitors of CDK2 using the REPLACE strategy PN Premnath, SN Craig, S Liu, C McInnes Bioorganic & medicinal chemistry letters 26 (15), 3754-3760, 2016 | 6 | 2016 |
| A novel isoform of Homeodomain-interacting protein kinase-2 promotes YAP/TEAD transcriptional activity in NSCLC cells Y Dai, H Kyoyama, YL Yang, Y Wang, S Liu, Y Wang, JH Mao, Z Xu, ... Oncotarget 12 (3), 173, 2021 | 4 | 2021 |
| Cyclin Based Inhibitors of CDK2 and CDK4 C McInnes, S Liu US Patent App. 13/940,407, 2014 | 4 | 2014 |
| Cyclin Based Inhibitors of CDK2 and CDK4 C McInnes, S Liu US Patent App. 13/851,661, 2013 | 3 | 2013 |
| MK256 is a novel CDK8 inhibitor with potent antitumor activity in AML through downregulation of the STAT pathway JC Lee, S Liu, Y Wang, Y Liang, DM Jablons Oncotarget 13, 1217, 2022 | 2 | 2022 |
